Pcas SA
PAR:PCA

Watchlist Manager
Pcas SA Logo
Pcas SA
PAR:PCA
Watchlist
Price: 8 EUR Market Closed
Market Cap: 109.9m EUR

Wall Street
Price Targets

PCA Price Targets Summary
Pcas SA

There are no price targets for PCA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Pcas SA Competitors:
Price Targets
SHC
Sotera Health Co
27% Upside
GSS
Genetic Signatures Ltd
86% Upside
603259
WuXi AppTec Co Ltd
42% Upside
NANOFH
Nanoform Finland Oyj
221% Upside
688114
MGI Tech Co Ltd
14% Upside
WST
West Pharmaceutical Services Inc
38% Upside
4880
CellSource Co Ltd
43% Upside
PSNL
Personalis Inc
56% Upside

Revenue
Forecast

Revenue Estimate
Pcas SA

For the last 8 years the compound annual growth rate for Pcas SA's revenue is 4%. The projected CAGR for the next 4 years is -2%.

4%
Past Growth
-2%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Pcas SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss

Net Income
Forecast

Net Income Estimate
Pcas SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PCA's stock price target?
Not Available

PCA doesn't have any price targets made by Wall Street professionals.

What is Pcas SA's Revenue forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for Pcas SA's revenue is 4%. The projected CAGR for the next 4 years is -2%.

Back to Top